SARS-CoV2 (COVID-19) Seroepidemiological Transplanted Subjects (Kidney, Kidney-pancreas, Pancreas, Langerhans Islets)

A Study to Assess the Role of Fenofibrate in Preventing Ischemic Cholangiopathy After Liver Transplantation

NCT05514119 ·Status: TERMINATED ·Phase: PHASE2

COVID-19 in Patients With Chronic Liver Diseases

NCT04439084 ·Status: COMPLETED

Evaluation of the Effectiveness of the Use of a Carnitine-Orotate Complex and Biphenyl Dimethyl Dicarboxylate in the Pathogenetic Therapy of Metabolic-associated Fatty Liver Disease: a Prospective Cohort Study

NCT06078722 ·Status: UNKNOWN

Safety, Tolerability, and Efficacy of Saroglitazar Mg 4 mg in Liver Transplant Recipients With Nonalcoholic Fatty Liver Disease (NAFLD)

NCT03639623 ·Status: COMPLETED ·Phase: PHASE2

The Spectrum and Profile of COVID-19 Infection and Its Impact on Liver.

NCT04345640 ·Status: UNKNOWN

Lipids and Neurological Complications in Liver Transplantation

NCT02544919 ·Status: UNKNOWN ·Phase: PHASE4

A Study of Liposomal Trans Crocetin, LEAF-4L6715, in Patients With Acute Respiratory Distress Syndrome Due to COVID-19, Sepsis or Other Causes

NCT04378920 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Metabolic Cofactor Supplementation in Obese Patients With Non-Alcoholic Fatty Liver Disease

NCT04330326 ·Status: COMPLETED ·Phase: PHASE2

6-week Safety and PD Study in Adults With NAFLD

NCT03256526 ·Status: COMPLETED ·Phase: PHASE2

Fecal Microbiome Transplantation in Cirrhosis: Trial in Patients With Decompensated Cirrhosis

NCT06533852 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3

Effect of LIK066 on Reduction of Fatty Content in Livers of Obese Patients

NCT03205150 ·Status: COMPLETED ·Phase: PHASE2

A Research Study Looking at How a Single Dose of the Study Medicine NNC0194-0499 Behaves in Participants With Reduced Liver Function Compared to Participants With Normal Liver Function

NCT05917938 ·Status: COMPLETED ·Phase: PHASE1

An Investigational Study to Evaluate Experimental Medication BMS-986036 in Participants With Different Levels of Kidney Function

NCT03674476 ·Status: COMPLETED ·Phase: PHASE1

Effect of Saccharomyces Boulardii in Patients in the Waiting List for Liver Transplant

NCT01762748 ·Status: COMPLETED ·Phase: PHASE2

The Study of Multiple Doses of CM-101 in Male and Female NAFLD (Nonalcoholic Fatty Liver Disease) and NAFLD/NASH (Nonalcoholic Steatohepatitis) Subjects

NCT06044467 ·Status: COMPLETED ·Phase: PHASE1

Human Fetal Liver Cell Transplantation in Chronic Liver Failure

NCT01013194 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Liver Function Test Abnormalities in COVID-19

NCT04763395 ·Status: COMPLETED

Safety and Efficacy Study of Lusutrombopag for Thrombocytopenia in Patients With Chronic Liver Disease Undergoing Elective Invasive Procedures

NCT02389621 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety of Rifaximin in Treating MAFLD

NCT07185932 ·Status: RECRUITING ·Phase: EARLY_PHASE1

Danazol for Treatment of Cytopenias in Patients With Cirrhosis

NCT04873102 ·Status: RECRUITING ·Phase: PHASE2

Study of PF-05221304 in Subjects With Varying Degrees of Hepatic Impairment

NCT03309202 ·Status: COMPLETED ·Phase: PHASE1

Octreotide vs. Splenic Artery Ligation for Portal Flow Modulation in Living Donor Liver Transplants (SCALOP Trial)

NCT06974344 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4

Pharmacokinetic (PK) and Safety Study of Iptacopan (LNP023) in Participants With Mild, Moderate, and Severe Hepatic Impairment Compared to Matched Control Healthy Participants With Normal Hepatic Function.

NCT05078580 ·Status: COMPLETED ·Phase: PHASE1

The Impact of Everolimus Based Immunosuppression in the Evolution of Hepatitis C Fibrosis After Liver Transplantation

NCT01707849 ·Status: COMPLETED ·Phase: PHASE3

Pilot Trial of Eculizumab Therapy to Reduce Preservation Injury in Human Macrosteatotic Liver Transplantation

NCT03468140 ·Status: WITHDRAWN ·Phase: EARLY_PHASE1